Vincerx Pharma, Inc. Noninterest Expense Offering Cost
Vincerx Pharma, Inc. had Noninterest Expense Offering Cost of $30.00 million as of 2025-01-21, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:NoninterestExpenseOfferingCost · last filed 2025-05-15
- 2025-01-21: Noninterest Expense Offering Cost $30.00M.
- 2024-12-31: Noninterest Expense Offering Cost $47.50M.
- 2024-09-30: Noninterest Expense Offering Cost $47.50M.
- 2024-06-30: Noninterest Expense Offering Cost $47.50M.
| Period end | Noninterest Expense Offering Cost |
|---|---|
| 2025-01-21 | $30.00M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $47.50M 10-K · filed 2025-03-27 |
| 2024-09-30 | $47.50M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $47.50M 10-Q · filed 2024-08-08 |
| 2024-03-29 | $50.00M 10-K · filed 2025-03-27 |